Ribocure Pharmaceuticals AB
ABActiveOrg 5593664377Vetenskapens Gränd 11, 431 53 MölndalResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2022 · 4 years old50-99 employees
Loading company…
Ribocure Pharmaceuticals AB is a Swedish AB based in Mölndal, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2022, the company reported revenue of 87,5 mn kr in its latest annual filing.
In its most recent annual report (2024), Ribocure Pharmaceuticals AB reported revenue of 87,5 mn kr, an increase of 44% on the year before. The figures on this page draw on 3 annual filings covering 2022 to 2024. The bottom line showed a net profit of 2,7 mn kr, and the EBITDA margin stood at 6.5%.
At the end of 2024, equity financed 51.8% of the balance sheet, and current assets covered short-term debt 1.8 times.